Intravenous vitamin C rides to the rescue again — this time it’s the treatment of rheumatoid arthritis

The power of vitamin C never fails to amaze me.

We’ve seen how intravenous mega-doses can kill cancer cells. And it does this with zero damage to healthy cells.

That puts C in the ranks of great medical treatments. But intravenous ascorbic acid (IAA) has much more to offer. Apparently, it works a small miracle in rheumatoid arthritis patients.

The Riordan Clinic is the leader in IAA research. Riordan researchers recently tested IAA on RA patients. All subjects had elevated levels of C-reactive protein. As I’ve mentioned before, CRP measures inflammation.

IAA doses up to 50 grams cut CRP levels almost in half. Patients also reported significant pain reduction.

The Riordan team believes that cartilage has a chance to regenerate when C neutralizes oxidative stress.

And there’s an added bonus. Reduced inflammation also cuts your risk of cardiovascular problems.

Sources:
“Effect of high dose intravenous ascorbic acid on the level of inflammation in patients with rheumatoid arthritis” Modern Research in Inflammation, Vol. 1, No. 2, October 2012, scrip.org/journal